RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Vadgama, Jaydutt
One or more keywords matched the following items that are connected to Vadgama, Jaydutt
Item TypeName
Concept Antineoplastic Agents
Concept Antineoplastic Agents, Phytogenic
Concept Antineoplastic Agents, Alkylating
Academic Article Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NF?B signaling.
Academic Article Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
Academic Article FOXO1A is a target for HER2-overexpressing breast tumors.
Academic Article STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits.
Academic Article Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.
Academic Article Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells.
Academic Article Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer.
Academic Article Targeting of PP2Cd By a Small Molecule C23 Inhibits High Glucose-Induced Breast Cancer Progression In Vivo.
Academic Article AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer.
Academic Article Estrogen Receptor-? and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.
Academic Article The role of PPM1D in cancer and advances in studies of its inhibitors.
Academic Article Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA.
Academic Article Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies.
Academic Article A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes-Associated Breast Cancer.
Search Criteria
  • Antineoplastic Agents
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support